Miquel Nolla-Salas | Fungal Infections and Challenges in Treatment | Best Researcher Award

Posted on by Infectious

Best Researcher Award

Miquel Nolla-Salas
Unió-Consorci-Formació, Spain

Miquel Nolla-Salas
Affiliation Unió-Consorci-Formació
Country Spain
Scopus ID 6701580090
Documents 32
Citations 159
h-index 5
Subject Area Fungal Infections and Challenges in Treatment
Event International Research Awards on Infectious Diseases
ORCID 0000-0002-8765-5506

The Best Researcher Award recognition highlights the scholarly contributions of Miquel Nolla-Salas in the field of infectious diseases, with particular emphasis on fungal infections, candidiasis, intensive care medicine, and treatment challenges. Through research, supervision, clinical investigations, and scientific dissemination, the researcher has contributed to the advancement of evidence-based approaches that support improved understanding of opportunistic fungal diseases and their management in healthcare settings.[1]

Abstract

Miquel Nolla-Salas has developed an academic and clinical research profile focused on infectious diseases, critical care medicine, and fungal infections. His scientific work has addressed the epidemiology, diagnosis, prevention, and treatment of candidiasis and related opportunistic infections among hospitalized and critically ill patients. Through peer-reviewed publications, postgraduate supervision, and collaborative investigations, he has contributed to the generation of clinical evidence supporting therapeutic decision-making and improved patient management. His scholarly record demonstrates sustained engagement with infection control challenges and the advancement of medical knowledge relevant to healthcare professionals, researchers, and clinical institutions worldwide.[1][2]

Keywords

Fungal Infections, Candidiasis, Infectious Diseases, Intensive Care Medicine, Clinical Research, Antifungal Therapy, Epidemiology, Critical Care, Medical Education, Healthcare Outcomes.

Introduction

Research concerning fungal infections remains a significant component of infectious disease management due to increasing healthcare complexity and vulnerable patient populations. Miquel Nolla-Salas has participated in investigations examining infection prevalence, diagnostic methodologies, and therapeutic interventions that seek to reduce morbidity and improve treatment effectiveness in clinical environments.[2]

Research Profile

The researcher’s academic profile reflects interdisciplinary engagement across infectious diseases, intensive care medicine, and fungal pathogen management. His publication portfolio includes studies addressing candidiasis prevalence, therapeutic evaluation, and infection-related outcomes. Academic activities have additionally included postgraduate mentorship and thesis supervision, supporting the development of future researchers and healthcare professionals.[1][3]

Research Contributions

His research contributions have focused on improving understanding of invasive fungal infections, especially among critically ill patients. Investigations have explored disease identification, risk assessment, therapeutic strategies, and evidence-based clinical management. These contributions have supported broader discussions regarding early diagnosis and optimized antifungal interventions within healthcare systems.[2][4]

Publications

The researcher’s publication record consists of peer-reviewed scientific articles indexed within recognized scholarly databases. These publications address clinically relevant topics associated with infectious diseases and fungal treatment challenges. Citation metrics indicate continuing scholarly visibility and engagement within the scientific community.[1]

Research Impact

Research impact can be evaluated through publication output, citation activity, academic mentorship, and contributions to clinical practice discussions. The documented citation record reflects scholarly engagement with his findings. Furthermore, the translation of research knowledge into clinical contexts demonstrates relevance to healthcare improvement and infectious disease management initiatives.[1][5]

Award Suitability

Miquel Nolla-Salas demonstrates several characteristics commonly associated with recipients of research recognition awards. These include a sustained publication record, measurable citation performance, active participation in scholarly research, contributions to postgraduate supervision, and commitment to advancing knowledge related to fungal infections and treatment challenges. Such achievements align with the objectives of the International Research Awards on Infectious Diseases, which recognize impactful and evidence-based scientific contributions.[1][3]

Conclusion

The academic profile of Miquel Nolla-Salas reflects a career dedicated to addressing significant challenges in infectious diseases and fungal infection management. His scholarly activities, publication contributions, mentorship roles, and clinical research involvement collectively support recognition within the international research community. The body of work demonstrates ongoing relevance to healthcare practice, scientific advancement, and future investigations in infectious disease research.[1][4]

References

  1. Elsevier. (n.d.). Scopus author details: Miquel Nolla-Salas, Author ID 6701580090. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6701580090
  2. Miquel Nolla-Salas; Jordi Ibañez-Nolla. Candida in the ICU, Risk Management and Patient Safety.
    https://doi.org/10.3390/microorganisms14061200
  3. ORCID. (n.d.). Research profile of Miquel Nolla-Salas.
    https://orcid.org/0000-0002-8765-5506
  4. International Journal of Infectious Diseases (2024). Multifocal candidiasis can be considered a form of invasive candidiasis in critically non-neutropenic patients.
    https://doi.org/10.1016/j.ijid.2024.107171
  5. International Research Awards on Infectious Diseases. Award recognition and evaluation framework.
    https://infectious-diseases-conferences.pencis.com/

Eman Abdel-Wahab | Mechanism of Resistance | Best Researcher Award

Posted on by Infectious

Assoc. Prof. Dr. Eman Abdel-Wahab | Mechanism of Resistance | Best Researcher Award

Senior Researcher | Agricultural Research Center | Egypt

Dr. Eman Ibrahim El-Sayed Abdel-Wahab is a distinguished Senior Researcher in Genetics at the Agricultural Research Center (ARC), Giza, Egypt, recognized for her expertise in plant genetics, crop improvement, and sustainable agricultural systems. Since joining ARC in 2012, she has conducted extensive research on the genetic and molecular mechanisms underlying soybean resistance to pests such as the cotton leaf worm (Spodoptera littoralis) and lima bean pod borer (Etiella zinckenella), while also advancing knowledge in intercropping systems, legume productivity, water use efficiency, and biotic stress tolerance. She has authored or co-authored over 50 scientific publications, including journal papers, book chapters, and conference proceedings published by Springer, IGI Global, and Lambert Academic Publishing, with her research achieving 33 citations across 10 Scopus-indexed documents and an h-index of 4. Actively contributing to national research programs focused on enhancing food legume production, Dr. Abdel-Wahab has played a vital role in strengthening Egypt’s agricultural resilience and sustainability. In addition to her research, she has served as a reviewer and editorial board member for several international journals, earning more than 30 certificates of excellence in reviewing from reputed publishers. Her outstanding achievements have been recognized globally through honors such as the World Championship in Seed Yield (Soybean Varieties) and the Agricultural Management Fellowship from India. Through her pioneering work on genetic resistance mechanisms and crop development, Dr. Abdel-Wahab continues to make a lasting impact on agricultural innovation, food security, and sustainable farming systems.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Metwally, A. E. A., Safina, S., Abdel-Wahab, E., & Abdel-Wahab, S. (2021). Screening thirty soybean genotypes under solid and intercropping plantings in Egypt. Journal of Crop Science and Biotechnology, 24, 203–220.

Safina, S., Mohamed, H., Abdel-Wahab, E., & El-Moemen, M. (2018). Seed yield and its quality of some soybean varieties as affected by humic acid. Academia Journal of Agricultural Research, 6(5), 194–213.

Abdel-Wahab, E., Naroz, M., & Abd El-Rahman, S. (2019). Potential of some soybean varieties for resistance to lima bean pod borer (Etiella zinckenella) under field conditions. Research on Crops, 20(2), 389–398.

Abdel-Wahab, S., & Abdel-Wahab, E. (2020). Competitive and facilitative effects of intercropping some soybean varieties with corn under different soybean plant densities. Plant Archives, 20(2), 1631–1639.

Dr. Eman Ibrahim El-Sayed Abdel-Wahab’s research significantly advances sustainable agriculture by improving soybean productivity, pest resistance, and intercropping efficiency through genetic and molecular innovation. Her work enhances food security, optimizes land use in resource-limited environments, and supports the development of resilient crop systems vital for global agricultural sustainability.

Goran Augustin | Abdominal infections | Best Researcher Award

Posted on by Infectious

Dr. Goran Augustin | Abdominal infections | Best Researcher Award 

MD, PhD | University Hospital Centre Zagreb | Croatia

Dr. Goran Augustin, MD, PhD, is a distinguished abdominal surgeon and academic professional whose work integrates advanced surgical practice with translational medical research. His expertise encompasses complex abdominal and gastrointestinal procedures, minimally invasive surgery, and clinical innovations aimed at improving patient outcomes and surgical precision. Throughout his career, he has contributed significantly to scientific literature through a robust portfolio of publications in reputable international journals, reflecting his dedication to evidence-based surgical advancement and academic excellence. His research collaborations with leading national and global institutions have fostered interdisciplinary approaches to surgical science, combining clinical insight with technological innovation and biomedical research. As an advocate for global health and surgical education, Dr. Rakau has actively participated in initiatives aimed at improving healthcare accessibility, capacity building, and the development of standardized surgical practices across diverse healthcare systems. His scholarly and clinical contributions have had a notable influence on both academic and medical communities, inspiring advancements in surgical methodologies, postoperative care, and patient safety. Through his leadership in clinical research, mentorship of emerging surgeons, and unwavering commitment to enhancing the quality of surgical care worldwide, Dr. Patrick Rakau continues to exemplify excellence in modern abdominal surgery and medical scholarship. He has 6061 citations from 179 documents with an h-index of 36.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Age Is Not So Important for Risk Stratification in Early Cholecystectomy for Acute Calculous Cholecystitis: A Post-Hoc Analysis of the SPRiMACC Study Database. (2025). Medicina (Lithuania).

2. Anticoagulation management and outcomes in critically ill patients with acute mesenteric ischemia: An international study. (2025). Intensive Care Medicine.

3. Protective ileostomy creation after anterior resection of the rectum (PICARR): A decision-making exploring international survey. (2025). Updates in Surgery.

4. A Survey on the Management of Patients with Severe Traumatic Brain Injury During Pregnancy: The MAMA Study. (2025). Neurocritical Care.

5. Phase angle as a prognostic biomarker in metastatic colorectal cancer: A prospective trial. (2025). World Journal of Experimental Medicine.

Chalachew Yenew | Neglected Tropical Diseases | Best Paper Award

Posted on by Infectious

Mr. Chalachew Yenew | Neglected Tropical Diseases | Best Paper Award

Lecturer | Debre Tabor University | Ethiopia 

Dr. Chalachew Yenew Dinku is an accomplished Lecturer and Researcher at Debre Tabor University, Ethiopia, specializing in Environmental and Public Health, with a research focus on environmental and occupational exposure, antimicrobial resistance (AMR), infection prevention and control, One Health, and public health emergency management. He holds a Master of Science in Environmental Health Sciences from Jimma University, where his thesis on AMR contamination pathways received an international research grant and resulted in multiple peer-reviewed publications. He earned his Bachelor of Science in Environmental and Occupational Health and Safety from the University of Gondar, where his undergraduate research on hospital indoor bacterial contamination gained national recognition. With over nine years of professional experience, Dr. Yenew has held key academic and public health roles, including as a Public Health Emergency Surveillance Officer with the Ohio State University Global One Health Initiative and as a Public Health Officer under the Amhara Health Bureau, where he led health education, surveillance, and community health initiatives. At Debre Tabor University, he has served as a member of research committees, supervised postgraduate students, and secured major institutional research grants such as “Addressing Antimicrobial Resistance through a One Health Approach” and “Scabies Screening and Prevention”. Dr. Yenew has authored or co-authored over 55 scientific papers, with 35 published in reputable international journals, 15 as first or corresponding author, and several under review. His extensive editorial contributions include serving as an editor for BMC Public Health, a reviewer for multiple high-impact journals, and a conference presenter at more than 20 national and international scientific events. His research integrates advanced statistical and molecular approaches to tackle pressing public health challenges, bridging academia, policy, and practice. With 355 citations, 47 indexed documents, and an h-index of 9, Dr. Chalachew Yenew exemplifies scholarly excellence, leadership, and commitment to advancing sustainable, evidence-based One Health solutions globally.

Profiles: Scopus | ORCID

Featured Publications

1. Anteneh, R. M., Gashu, Z. E., Baffa, L. D., Bitew, D. A., Yenew, C., Demissie, K. A., Terefe, B., Jejaw, M., Zegeye, A. F., Tiruneh, M. G., et al. (2025). Decomposing socioeconomic and educational inequalities in infant mortality in Sub-Saharan Africa. BMC Public Health, 25(12), 1–12.

2. Mehari, M. G., Yeshiwas, A. G., Esubalew, D., Azmeraw, Y., Delie, A. M., Limenh, L. W., Worku, N. K., Hailu, M., Melese, M., Abie, A., et al. (2025). Dominance of antimicrobial resistant bacteria and risk factors of bacteriuria infection among pregnant women in East Africa. Journal of Health, Population and Nutrition, 25(12), 1–12.

3. Temesgen, A., Anteneh, R. M., Yeshiwas, A. G., Bayeh, G. M., Yenew, C., Ejigu, A. G., Gebeyehu, A. A., Tsega, T. D., Ahmed, A. F., Yemata, G. A., et al. (2025). Systematic review and meta-analysis on gaps in household waste management practices in urban Ethiopia for supporting the TSEDU Ethiopia initiative. Discover Sustainability, 25(12), 1–12.

4. Tsega, T. D., Tsega, S. S., Gebeyehu, A. A., Yemata, G. A., Anteneh, R. M., Yeshiwas, A. G., Yirdaw, G., Yenew, C., Enawgaw, A. S., Ejigu, A. G., et al. (2025). Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa. BMC Infectious Diseases, 25(12), 1–12.

Shayan Zamani | Antiviral Therapies and Resistance Mechanisms | Best Researcher Award

Posted on by Infectious

Dr. Shayan Zamani | Antiviral Therapies and Resistance Mechanisms | Best Researcher Award

MD | Tehran University of Medical Sciences | Iran

Dr. Shayan Zamani is a dedicated Clinical Research Fellow at the Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, where he has established a strong foundation in dermatology, oncology, and hematopoietic stem cell transplantation. He earned his Doctor of Medicine (MD) with a focus on dermatologic research and clinical therapeutics, combining his medical expertise with evidence-based research in complex dermatological and oncologic disorders. Throughout his career, Dr. Zamani has contributed to multidisciplinary research collaborations exploring topics such as graft-versus-host disease (GVHD), drug-resistant fungal infections, cutaneous complications in oncology patients, and innovative nanoliposomal treatments for fungal and inflammatory skin diseases. His professional experience spans both clinical and laboratory environments, where he integrates translational methodologies to improve diagnostic precision and patient outcomes. His research interests center on dermatologic oncology, infectious skin diseases, immunodermatology, and regenerative therapies, supported by his skills in clinical trial design, biomarker analysis, molecular diagnostics, and data-driven evaluation of treatment efficacy. Dr. Zamani has authored several peer-reviewed publications in reputable journals such as JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Frontiers in Oncology, and Dermatologic Therapy, contributing valuable insights into skin disease pathophysiology and treatment optimization. His work has earned him recognition for academic excellence and commitment to advancing medical science. Dr. Zamani has actively participated in research collaborations and conferences, reflecting strong leadership and dedication to clinical innovation. With a growing publication record and a clear focus on improving therapeutic outcomes, he continues to strengthen his role in advancing dermatologic and oncologic research globally. His academic impact is demonstrated by 19 citations , 11 publications, and an h-index of 3.

Profiles : Google Scholar | Scopus | ORCID

Featured Publications

1. Tamimi, P., Fattahi, M., Ghaderi, A., Firooz, A., Shirvani, F., Alkhen, A., & Zamani, S. (2024). Terbinafin‐resistente Trichophyton indotineae mit F397L/L393S‐ oder F397L/L393F‐Mutation bei Patienten mit Tinea incognita unter Glukokortikosteroiden. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 22(7), 922–935.

2. Samadi, A., Ayatollahi, A., Kashani, M. N., Zamani, S., & Firooz, A. (2023). Efficacy and tolerability assessment of a polynucleotide‐based gel for improvement of pattern hair loss: A polynucleotide‐based gel for improvement of pattern hair loss. [Journal name not specified].

3. Mehdizadeh, M., Tehrani, H. A., Rezvani, H., Zamani, S., Salari, S., & Hajifathali, A. (2023). Maintenance therapy with Everolimus in patients with refractory or relapsing Hodgkin lymphoma after autologous stem cell transplantation. Blood Cell Therapy, 6(3), 87–93.

4. Zamani, S., Azhdari, H., & Mehdizadeh, M. (2023). Efficacy and safety profile of Everolimus as a maintenance therapy for primary refractory/relapsing Hodgkin lymphoma following autologous hematopoietic stem cell transplantation. HemaSphere, 7(S3), e9236902.

5. Zamani, S., Mehdizadeh, M., & Salem, A. (2023). Allogeneic stem cell transplantation outcomes in Hodgkin lymphoma: A prognostic study of 30 patients with relapsed and refractory Hodgkin lymphoma. HemaSphere, 7(S3), e621289b.

 

Salauddin Al Azad | Infectious Diseases Prevention | Best Researcher Award

Posted on by Infectious

Dr. Salauddin Al Azad | Infectious Diseases Prevention | Best Researcher Award

Principal Investigator | Jiangnan University | China

Dr. Salauddin Al Azad is an accomplished researcher and CSC Scholar at the Key Laboratory of Industrial Biotechnology, Jiangnan University, China, and Principal Investigator of the RPG Interface Lab, Bangladesh. His research primarily focuses on synthetic biology, molecular engineering, and biorefinery processes for sustainable bioenergy production. He has made significant contributions to microbial lipid-based biorefineries, lignocellulosic biomass fractionation, molecular docking, and computational biochemistry. His expertise spans wet-lab techniques such as enzymatic hydrolysis, gene sequencing, and nanoencapsulation, as well as dry-lab and in silico methods including molecular dynamics simulation, density functional theory, and machine learning-driven bioprocess optimization. Salauddin’s multidisciplinary research integrates biochemistry, nanobiocomposite design, and immunoinformatics to develop advanced strategies for biofuel production, drug delivery, and enzyme stabilization. With 33 publications, including 20 indexed in SCI journals and 12 in Q1, his scientific contributions have gained substantial recognition, achieving 856 citations, an h-index of 19, and an i10-index of 25. His recent works in high-impact journals such as Biofuel Research Journal, Fuel, ACS Sustainable Chemistry & Engineering, and Bioresource Technology highlight innovations in green chemistry, computational modeling, and sustainable energy technologies. He has collaborated extensively with global research institutions and contributed as a reviewer and editorial board member for reputed publishers, reflecting his academic influence. Salauddin’s projects have been supported by the National Natural Science Foundation of China, the World Bank, and the Bangladesh Academy of Science, among others. His dedication to advancing molecular biotechnology, bioenergy, and material science has positioned him among the top global researchers in fields like biopolymer engineering, nanobiocomposites, and functional lipids. 492 Citations, 20 Documents, 13 h-index, View h-index.

Profiles :  Google Scholar | Scopus | ORCID

Featured Publications

Al Azad, S., Madadi, M., Saleknezhad, M., Zhang, E., & Sun, F. (2025). Machine learning-driven optimization of biphasic pretreatment conditions for enhanced lignocellulosic biomass fractionation. Energy, 136241. Cited by 8

Al Azad, S., Madadi, M., Rahman, A., Sun, C., Zhang, E., & Sun, F. (2025). Quantum mechanical insights into lignocellulosic biomass fractionation through an NaOH-catalyzed Triton-X 100 system: In vitro and in silico approaches. ACS Sustainable Chemistry & Engineering, 13(15), 5516–5530. Cited by 3